Gerrit A Meijer Selected Research

Tyrosine Kinase Inhibitors

2/2019	Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions.
10/2013	EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.
4/2006	Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerrit A Meijer Research Topics

Disease

96	Neoplasms (Cancer) 03/2024 - 12/2003
62	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 07/2005
39	Adenoma (Adenomas) 02/2024 - 01/2006
27	Carcinoma (Carcinomatosis) 11/2023 - 10/2005
21	Colonic Neoplasms (Colon Cancer) 12/2022 - 06/2009
11	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2007
9	Adenocarcinoma 01/2022 - 01/2006
8	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2013
7	Hodgkin Disease (Hodgkin's Disease) 12/2022 - 02/2017
6	Carcinogenesis 02/2021 - 01/2009
6	Microsatellite Instability 11/2018 - 07/2012
5	Chromosomal Instability (Chromosome Stability) 12/2022 - 04/2010
5	Breast Neoplasms (Breast Cancer) 09/2012 - 12/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2021
4	Chromosome Aberrations (Chromosome Abnormalities) 03/2009 - 11/2005
4	Genomic Instability 02/2008 - 01/2005
3	Testicular Neoplasms (Testicular Cancer) 11/2022 - 02/2021
3	Polyps 04/2021 - 01/2006
3	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2011
3	Hypoxia (Hypoxemia) 01/2016 - 12/2003
3	Aneuploidy (Aneuploid) 01/2014 - 09/2006
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2009
2	Metaplasia 05/2014 - 01/2004
2	Atrophy 01/2013 - 01/2004
2	Pulmonary Hypertension 08/2011 - 01/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2010 - 01/2009
2	Celiac Disease (Celiac Sprue) 05/2007 - 12/2005
2	Melanoma (Melanoma, Malignant) 09/2006 - 10/2005
1	Seminoma 11/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 04/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

60	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2005
37	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2007
34	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
24	Calcibiotic Root Canal SealerIBA 03/2024 - 12/2007
14	Messenger RNA (mRNA)IBA 12/2023 - 07/2008
11	ParaffinIBA 01/2021 - 12/2003
10	Formaldehyde (Formol)FDA Link 01/2021 - 11/2008
8	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2019
6	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2005
6	MicroRNAs (MicroRNA)IBA 10/2022 - 07/2008
6	ErbB Receptors (EGF Receptor)IBA 12/2020 - 04/2006
6	Aurora Kinase AIBA 01/2018 - 04/2010
5	Procarbazine (Matulane)FDA Link 12/2022 - 02/2017
4	Circulating Tumor DNAIBA 01/2023 - 12/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 12/2022 - 09/2016
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 05/2008
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 10/2011
3	AntibodiesIBA 12/2020 - 01/2008
3	Tyrosine Kinase InhibitorsIBA 02/2019 - 04/2006
3	Peptides (Polypeptides)IBA 10/2018 - 12/2005
3	Small Interfering RNA (siRNA)IBA 10/2017 - 06/2009
3	Versicans (Versican)IBA 01/2017 - 09/2012
3	ChromatinIBA 05/2014 - 02/2007
3	ProteomeIBA 03/2014 - 05/2010
3	Cyclin D1IBA 07/2012 - 12/2003
2	SerpinsIBA 02/2024 - 01/2021
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2024 - 01/2021
2	PlatinumIBA 11/2022 - 02/2021
2	Secretory Leukocyte Peptidase InhibitorIBA 01/2022 - 10/2020
2	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2018 - 04/2008
2	Complement System Proteins (Complement)IBA 12/2017 - 09/2014
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 12/2013
2	LumicanIBA 01/2017 - 12/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 11/2007
2	CarbohydratesIBA 09/2015 - 07/2005
2	Carrier Proteins (Binding Protein)IBA 05/2014 - 06/2009
2	A-Form DNA (A-DNA)IBA 05/2014 - 08/2011
2	Cetuximab (Erbitux)FDA Link 07/2012 - 04/2008
2	Polysaccharides (Glycans)IBA 07/2012 - 08/2007
2	Carcinoembryonic AntigenIBA 07/2012 - 07/2005
2	AntigensIBA 07/2012 - 10/2005
2	Mucin-1 (CA 15-3 Antigen)IBA 07/2012 - 08/2007
2	OligonucleotidesIBA 02/2012 - 03/2009
2	MonocrotalineIBA 08/2011 - 01/2010
2	Nonsense Codon (Nonsense Mutation)IBA 03/2010 - 06/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2009 - 06/2007
2	Gemcitabine FDA Link 04/2008 - 11/2005
2	C-Type Lectins (C-Type Lectin)IBA 08/2007 - 07/2005
1	Polyketide SynthasesIBA 03/2024
1	Unithiol (DMPS)IBA 03/2024
1	NivolumabIBA 12/2023
1	Indicators and Reagents (Reagents)IBA 10/2022
1	NexusIBA 01/2022
1	theasinensin AIBA 04/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2021
1	Cisplatin (Platino)FDA LinkGeneric 02/2021
1	CDX2 Transcription FactorIBA 01/2021
1	N 30IBA 01/2021

Therapy/Procedure

19	Therapeutics 01/2023 - 10/2005
12	Drug Therapy (Chemotherapy) 11/2022 - 04/2006
10	Adjuvant Chemotherapy 04/2022 - 01/2012
7	Radiotherapy 12/2022 - 01/2012
4	Ligation 01/2018 - 11/2008
3	Neoadjuvant Therapy 08/2021 - 05/2015
2	Aftercare (After-Treatment) 01/2022 - 02/2017
2	Immunotherapy 01/2016 - 02/2012
1	Precision Medicine 11/2023
1	Subcutaneous Injections 10/2022